• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anticoagulation in Acute Stroke: Early Claims and Later Doubts.

作者信息

Wijdicks Eelco F M

机构信息

Neurocritical Care Services, Saint Marys Hospital Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

出版信息

Neurocrit Care. 2024 Nov 12. doi: 10.1007/s12028-024-02160-6.

DOI:10.1007/s12028-024-02160-6
PMID:39532774
Abstract
摘要

相似文献

1
Anticoagulation in Acute Stroke: Early Claims and Later Doubts.急性卒中的抗凝治疗：早期的主张与后来的质疑
Neurocrit Care. 2024 Nov 12. doi: 10.1007/s12028-024-02160-6.
2
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation.早期与晚期抗凝治疗房颤相关性脑卒中。
N Engl J Med. 2023 Jun 29;388(26):2411-2421. doi: 10.1056/NEJMoa2303048. Epub 2023 May 24.
3
Early vs late anticoagulation in acute ischemic stroke with indications outside atrial fibrillation.急性缺血性卒中伴非心房颤动适应证的早期与晚期抗凝治疗。
J Stroke Cerebrovasc Dis. 2024 Jul;33(7):107757. doi: 10.1016/j.jstrokecerebrovasdis.2024.107757. Epub 2024 May 3.
4
Early anticoagulation in atrial fibrillation-related acute ischaemic stroke: efficacy and safety profile.心房颤动相关急性缺血性卒中的早期抗凝治疗：疗效和安全性概况。
J Neurol. 2022 Apr;269(4):2099-2112. doi: 10.1007/s00415-021-10788-z. Epub 2021 Sep 9.
5
Early Apixaban Use Following Stroke in Patients With Atrial Fibrillation: Results of the AREST Trial.房颤患者卒中后早期应用阿哌沙班：AREST 试验结果。
Stroke. 2021 Apr;52(4):1164-1171. doi: 10.1161/STROKEAHA.120.030042. Epub 2021 Feb 25.
6
Effect of the COVID-19 pandemic on adversity in individuals receiving anticoagulation for atrial fibrillation: A nationally representative administrative health claims analysis.2019年冠状病毒病疫情对接受心房颤动抗凝治疗患者的逆境影响：一项具有全国代表性的行政医保理赔分析
Am Heart J Plus. 2022 Jan;13:100096. doi: 10.1016/j.ahjo.2022.100096. Epub 2022 Feb 4.
7
Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation-A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation.AREST研究方案：阿哌沙班用于复发性栓塞性中风和出血性转化的早期预防——心房颤动急性缺血性中风后早期抗凝的随机对照试验
Front Neurol. 2019 Sep 20;10:975. doi: 10.3389/fneur.2019.00975. eCollection 2019.
8
Continuation or Discontinuation of Anticoagulation in the Early Phase After Acute Ischemic Stroke.急性缺血性脑卒中后早期抗凝的持续或中断。
Stroke. 2018 Jul;49(7):1762-1765. doi: 10.1161/STROKEAHA.118.021514. Epub 2018 May 29.
9
Do population studies confirm the benefit of oral anticoagulation in atrial fibrillation demonstrated in clinical trials?人群研究是否证实了临床试验中所显示的口服抗凝药在房颤治疗中的益处？
J Interv Card Electrophysiol. 2004;10 Suppl 1:9-16. doi: 10.1023/B:JICE.0000011340.74632.ac.
10
The economic burden of ischemic stroke and major hemorrhage in medicare beneficiaries with nonvalvular atrial fibrillation: a retrospective claims analysis.医疗保险受益的非瓣膜性心房颤动患者缺血性卒中和重大出血的经济负担：一项回顾性索赔分析。
Am Health Drug Benefits. 2014 Jun;7(4):200-9.

本文引用的文献

1
THE USE OF HEPARIN IN THROMBOSIS.肝素在血栓形成中的应用。
Ann Surg. 1938 Aug;108(2):163-77. doi: 10.1097/00000658-193808000-00002.
2
The chemistry of heparin.肝素的化学性质。
Biochem J. 1935 Aug;29(8):1817-30. doi: 10.1042/bj0291817.
3
Anticoagulant therapy in cerebral infarction. Report on cooperative study.
Neurology. 1962 Dec;12:823-35. doi: 10.1212/wnl.12.12.823.
4
A profile of cerebral vascular accidents today.当今脑血管意外概述。
GP. 1959 Feb;19(2):117-23.
5
When should heparin be given to patients with atrial fibrillation-related embolic brain infarcts?房颤相关性栓塞性脑梗死患者应何时给予肝素？
Arch Neurol. 1999 Sep;56(9):1059-60. doi: 10.1001/archneur.56.9.1059.
6
Vertebrobasilar disease. Time for a new strategy.椎基底动脉疾病。是时候采用新策略了。
Stroke. 1981 Jan-Feb;12(1):111-4. doi: 10.1161/01.str.12.1.111.
7
To heparinize or not: an unsettled issue.是否使用肝素：一个尚未解决的问题。
Stroke. 1989 Jul;20(7):968.
8
Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.华法林与阿司匹林预防慢性心房颤动血栓栓塞并发症的安慰剂对照随机试验。哥本哈根AFASAK研究。
Lancet. 1989 Jan 28;1(8631):175-9. doi: 10.1016/s0140-6736(89)91200-2.